[go: up one dir, main page]

GB0526351D0 - Novel benzamide derivatives - Google Patents

Novel benzamide derivatives

Info

Publication number
GB0526351D0
GB0526351D0 GBGB0526351.2A GB0526351A GB0526351D0 GB 0526351 D0 GB0526351 D0 GB 0526351D0 GB 0526351 A GB0526351 A GB 0526351A GB 0526351 D0 GB0526351 D0 GB 0526351D0
Authority
GB
United Kingdom
Prior art keywords
benzamide derivatives
novel benzamide
novel
derivatives
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0526351.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0526351.2A priority Critical patent/GB0526351D0/en
Publication of GB0526351D0 publication Critical patent/GB0526351D0/en
Priority to PCT/GB2006/004744 priority patent/WO2007071956A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0526351.2A 2005-12-23 2005-12-23 Novel benzamide derivatives Ceased GB0526351D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0526351.2A GB0526351D0 (en) 2005-12-23 2005-12-23 Novel benzamide derivatives
PCT/GB2006/004744 WO2007071956A1 (en) 2005-12-23 2006-12-19 Novel benzamide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0526351.2A GB0526351D0 (en) 2005-12-23 2005-12-23 Novel benzamide derivatives

Publications (1)

Publication Number Publication Date
GB0526351D0 true GB0526351D0 (en) 2006-02-01

Family

ID=35841161

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0526351.2A Ceased GB0526351D0 (en) 2005-12-23 2005-12-23 Novel benzamide derivatives

Country Status (2)

Country Link
GB (1) GB0526351D0 (en)
WO (1) WO2007071956A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0521244D0 (en) 2005-10-19 2005-11-30 Astrazeneca Ab Benzamide compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI319387B (en) * 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
GB0501146D0 (en) * 2005-01-20 2005-02-23 Astrazeneca Ab Novel benzamide derivatives

Also Published As

Publication number Publication date
WO2007071956A1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
EP1878727A4 (en) 2-aminoquinazoline derivatives
ZA200805411B (en) Aryl-isoxazolo-4-yl-oxadiazole derivatives
ZA200707358B (en) 1-benzylindole-2-carboxamide derivatives
HUS2000022I1 (en) Tiglien-3-one derivatives
ZA200802088B (en) 4-Phenyl-6-substitued-pyrimidine-2-carbonitrile derivatives
AP2108A (en) Novel biphenylsulfonamides
ZA200802421B (en) 1-Acyldihydropyrazol derivatives
ZA200804257B (en) Azaindole-2-carboxamide derivatives
IL192235A0 (en) Aryl-isoxazol-4-yl-imidazole derivatives
PT1908753E (en) Novel heterocyclidene acetamide derivative
PL1954674T3 (en) New n-phenethylcarboxamide derivatives
IL191138A0 (en) Pyrazoloisoquinoline derivatives
GB0521244D0 (en) Benzamide compounds
GB0505954D0 (en) Novel use
IL188848A0 (en) Novel heterocyclidene acetamide derivative
GB0501146D0 (en) Novel benzamide derivatives
GB0500828D0 (en) Benzamide derivatives
GB0506001D0 (en) Novel use
EP1846443A4 (en) Novel use
GB0511410D0 (en) Benzotrizepinone derivatives
ZA200706577B (en) Dihydroimidazothiazole derivatives
GB0526352D0 (en) Benzamide derivatives
GB0526351D0 (en) Novel benzamide derivatives
GB0506165D0 (en) Benzamide compounds
GB0513999D0 (en) Benzamide compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)